MLKL can also trigger necroptosis independently of Ripk3 in tanshinol A-induced lung cancer cell death [55], anti-CD147 antibody-induced hepatocellular carcinoma cell death [16], radiation-induced antitumor immunity [56], and autoimmune hepatitis [57]. Here, RIPK3 is linked to lung carcinoma.